awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34708696-21B0FA42-5C33-49A7-B291-DC45FBA79EE2
Q34708696-21B0FA42-5C33-49A7-B291-DC45FBA79EE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34708696-21B0FA42-5C33-49A7-B291-DC45FBA79EE2
Evaluation of nuclear factor κB and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610
P2860
Q34708696-21B0FA42-5C33-49A7-B291-DC45FBA79EE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34708696-21B0FA42-5C33-49A7-B291-DC45FBA79EE2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
610487cb5b73c7cbf6cb356d86b050940e959881
P2860
Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.